Searchable abstracts of presentations at key conferences in endocrinology

ea0081p767 | Late-Breaking | ECE2022

Correlation of adiponectin and resistin with atherogenic markers in insulin resistant and non-insulin resistant adolescent women with polycystic ovary syndrome

Atanasova Boshku Aleksandra , Ivanova Panova Daniela

Aim: To evaluate adiponectin and resistin levels and their relationship with various biochemical and metabolic and atherogenic parameters markers, as well as their correlation, and to investigate its contribution in pathogenesis of insulin resistance in cohort women with PCOS and of insulin resistance as well as in non-insulin resistant women with PCOS. Methods: This study was designed as a cross-sectional and involves 80 premenopausal women. Of these patients, 63 females have...

ea0081ep159 | Calcium and Bone | ECE2022

Long term treatment with teriparatide in hypoparathyroidism

Spada Antonio , Bosco Daniela , Santonati Assunta

Hypoparathyroidism is, in Italy, an orphan disease because the hormonal replacement therapy is possible only with teriparatide (fragment 1–34 of of human parathyroid hormone). Otherwise the patients use oral calcium and calcitriol. This scheme of therapy obtained correct plasmatic calcium and phosphate levels, correct urinary excretion of calcium and phosphate, adequate quality of life – QoL only in a little percentage of patients. Especially kidney stones, intra-ren...

ea0032p662 | Male reproduction | ECE2013

Testosterone undecanoate 1000 mg at 3 months does not increase prostatic specific antigen level: study on over 100 patients, December 2012

Pisoschi Matei , Cristina Staicu Daniela , Peretianu Dan

Aim: To find if testosterone undecanoat 1000 mg injection (Nebido; Bayer-Schering) has a negative effect on prostate.Materials and methods: i) PSA (ng/ml) was registred retrospective (from files) and prospective analysis (onset 2010). ii) From over 175 patients to whom testosterone undecanoate 1000 mg, i.m. was administrated at 3 months, in the last 4 years, and to whom the prostatic volume was quantified (Journal of Sexual Medicine8</st...

ea0016p772 | Thyroid | ECE2008

Usefulness of thyroid echographic pattern description: predictive value at onset and in the evolution of thyroid diseases

Peretianu Dan , Staicu Daniela Cristea , Carsote Mara

Objectives: The study of the real indications for thyroid ultrasound and in which pathological conditions the echography is of real use and not for abuse.Material and methods: In the last 10 years, over 13 000 echographies were performed in 5136 consecutive patients for ‘thyroid disturbances’. In a previous paper we described 7 echographic patterns for thyroid ultrasound (9th ECE). The diagnosis of Hashimoto’s thyroiditis (HT) was consider...

ea0063gp48 | Acromegaly and GH | ECE2019

Prolonged diagnostic delay in acromegaly is associated with long-term morbidity and excess mortality: data from a nationwide study

Esposito Daniela , Ragnarsson Oskar , Johannsson Gudmundur , Olsson Daniel S

Background: Clinical features of acromegaly develop insidiously and the diagnosis is often delayed. However, diagnostic delay (DD) in acromegaly has not been systematically investigated. Our primary aim was to investigate DD in a nationwide cohort of patients with acromegaly. Secondary aim was to study the impact of DD on morbidity and mortality.Methods: Adult patients diagnosed with acromegaly between 2001 and 2013 were identified in the Swedish Nationa...

ea0049ep297 | Calcium &amp; Vitamin D metabolism | ECE2017

Tc-99m sestamibi uptake by brown tumours in a patient with primary hyperparathyroidism

Dias Daniela , Macedo Daniel , Santos Rita , Leite Valeriano

Tc-99m sestamibi (MIBI) imaging is able to localize parathyroid adenomas/carcinomas in patients with primary hyperparathyroidism. Brown tumours are one of the skeletal manifestations of long standing hyperparathyroidism and its incidence has been reported to be 3%. Radiological features of these tumors may mimic bone metastasis. There are only a few reports showing brown tumours uptake in the whole-body Tc-sestamibi scan.We report a 72-year-old female wi...

ea0041gp147 | Paediatric Endocrinology &amp; Development | ECE2016

Prenatal metformin treatment prevents estradiol increase and partially improves ovarian function in offspring of obese mothers

Alvarez Daniela , Olguin Sofia , Ceballo Karina , Martinez Jonathan , Cerda Tania , Fernandois Daniela , Cruz Gonzalo

Obesity epidemic is one of the major concerns in the world. Worryingly, a high percentage of pregnant women have obesity, which could imply several consequences. Maternal obesity leads to different abnormalities in pregnancy and delivery. In addition, recent studies show that the offspring of obese mothers has an increased probability to suffer cardiovascular, metabolic and reproductive diseases. We have previously demonstrated that exposure to a high fat diet is related to ob...

ea0015p126 | Diabetes, metabolism and cardiovascular | SFEBES2008

Identification of a circadian clock within adipocyte cells

Otway Daniella , Frost Gary , Johnston Jonathan

Multiple aspects of physiology and pathophysiology, including endocrine function, are influenced by endogenous circadian timing mechanisms. In mammals, cell autonomous clocks are present in all major tissues throughout the body. These clocks are synchronised via complex signalling pathways and are believed to drive local aspects of physiology.Recently published data have revealed 24-h rhythms in up to 20% of the adipose transcriptome, suggesting profound...

ea0081p297 | Calcium and Bone | ECE2022

Phenotype characterization of a PHEX non canonical splice-site mutation in a family affected by X linked hypophosphatemic rickets and efficacy of one-year Burosumab treatment in adult patients

Di Fraia Rosa , Digitale Selvaggio Lucia , Allosso Francesca , Pasquali Daniela

X-linked hypophosphatemic rickets (XLH) is associated with mutations in PHEX, upregulation of FGF23, leading to hypophosphatemia, abnormal bone development and short stature. H-MAB to FGF23, Burosumab, is the new therapy for XLH. Among PHEX mutations, c.1586+6T >C, partially destroying the splice-site, is presumably associated to a mild phenotype not described so far. We describe two siblings bearing the PHEX c.1586+6T >C variant. Cas...

ea0081ep509 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Is Semaglutide superior than Liraglutide in patients with type 2 diabetes on insulin therapy? - case presentation

Mickovski Ivana , Buklioska-Ilievska Daniela , Milosheska Radmila , Hasan Taner

Type 2 diabetes (T2DM) is a chronic and progressive disease associated with microvascular and macrovascular complications leading to increased morbidity and mortality. Insulin remains the cornerstone therapy for longer-duration T2DM and b-cell failure. Glucagon-like peptide-1 receptor agonists are a class of multifactorial T2DM medications that have been shown to improve numerous risk factors for diabetes-related complications, including glycemic control, reduction in body wei...